Good to see more European centres opened for the trial. The rate of stem cell transplants in Italy and France are 9.4 and 8.6 per 100,000 people, compared to approximately 6.8 per 100,000 people in the USA [2]. More transplants unfortunately = More GvHD and the opportunity for patients to be treated with Cymerus iPSC derived MSCs worth hundreds of thousands of dollars (if you believe Silviu Itescu).
[1]: https://ec.europa.eu/eurostat/en/web/products-eurostat-news/-/edn-20201010-1
[2]: https://bloodstemcell.hrsa.gov/data/donation-and-transplantation-statistics
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
17.0¢ |
Change
-0.005(2.86%) |
Mkt cap ! $38.41M | |||
| Open | High | Low | Value | Volume |
| 18.0¢ | 18.0¢ | 16.5¢ | $40.58K | 239.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 113914 | 16.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 17.0¢ | 5145 | 2 |
View Market Depth
| Last trade - 11.48am 30/07/2025 (20 minute delay) ? |
| CYP (ASX) Chart |